Moneycontrol PRO
HomeNewsIndiaDelhi close to attaining herd immunity as 50% population has COVID-19 antibodies: Sero survey

Delhi close to attaining herd immunity as 50% population has COVID-19 antibodies: Sero survey

The latest sero-survey has found that every second person in Delhi has developed antibodies against the novel coronavirus. Meaning, out of the over two-crore people residing in Delhi, nearly one crore persons have already contracted COVID-19 and recovered from it.

January 25, 2021 / 20:15 IST

Delhi conducted its fifth sero-prevalence survey in January and the results have revealed that the National Capital is inching closer towards attaining herd immunity against COVID-19.

The latest sero-survey has found that every second person in Delhi has developed antibodies against the novel coronavirus. Meaning, out of the over two-crore people residing in Delhi, nearly one crore people have already contracted COVID-19 and recovered from it.
What is a sero-survey and will it help in the fight against COVID-19?

Though the Delhi government is yet to announce the result of the survey, a source privy to it has revealed: “In one district, the sero-prevalence rate is between 50-60 percent, indicating a large number of people have developed antibodies, so we can say the city is moving towards attaining herd immunity.”

A population is deemed to have attained herd immunity if 50 to 60 percent of the people are found to have developed antibodies during a sero-prevalence survey.

Notably, this was the fifth sero-survey conducted in Delhi; it was kicked off on January 11 and 28,000 samples were collected during the exercise.6.6% Indians aged above 10 were exposed to COVID-19 by August: Sero-survey

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The first one was done in July 2020 and had revealed that 23 percent of the surveyed population had developed antibodies against COVID-19.

The previous serological survey conducted in Delhi in October had revealed that 25.5 percent of the population had COVID-19 antibodies. The September survey had shown sero-prevalence in 25.1 percent of the population, while the August survey had found antibodies in 29.1 percent of Delhi’s population.

With PTI inputs

Follow our coverage of the coronavirus crisis here

Moneycontrol News
first published: Jan 25, 2021 08:06 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347